Featured Research

from universities, journals, and other organizations

Physiological role of a novel hormone FNDC5/irisin revealed in humans

Date:
October 1, 2012
Source:
Elsevier
Summary:
Scientists have elucidated the molecular and clinical role of FNDC5/irisin in humans. Irisin is a recently identified hormone secreted from muscle cells that has been found to serve as a chemical messenger providing key exercise-induced health benefits in mice. In these earlier studies, irisin showed direct effects on ‘browning’ of white fat which would lead to burning of excess calories. Discovery of irisin therefore raised expectations of potential for developing new therapies for metabolic diseases.

A research team led by Dr. Christos Mantzoros, MD, PhD, at Beth Israel Deaconess Medical Center, Harvard Medical School, has published new findings elucidating the molecular and clinical role of FNDC5/irisin in humans.

Related Articles


Irisin is a recently identified hormone secreted from muscle cells that has been found to serve as a chemical messenger providing key exercise-induced health benefits in mice. In these earlier studies, irisin showed direct effects on 'browning' of white fat which would lead to burning of excess calories. Discovery of irisin therefore raised expectations of potential for developing new therapies for metabolic diseases.

In their study, Dr. Mantzoros and his team of researchers went one step further by uncovering the role of irisin in humans. They reported that whereas the cleaved soluble part of the FNDC5 molecule (irisin) is readily detectable in human plasma, the uncleaved and unprocessed molecule FNDC5 is only rarely detectable.

They studied possible predictors of circulating irisin concentrations by performing cross-sectional and interventional studies in humans. They found that irisin levels reflect muscle mass primarily and are higher in younger male athletes than in older women. Also, muscle mRNA expression of FNDC5 was strongly and positively correlated with PGC1-α mRNA levels which confirms irisin as a myokine, a hormone secreted by muscle.

The Mantzoros group addressed the controversy of whether irisin levels change in humans during exercise by comparing levels in young healthy males who performed acute sprint runs and chronic sprint training for eight weeks. The results showed that irisin levels increase in response to acute exercise and irisin levels are closely and negatively associated with muscle ATP levels, pointing to a need for a prompt secretion of irisin after acute exercise to meet the needs for ATP and metabolite synthesis in muscle. Also reported were associations of irisin with growth factors, which increase muscle mass and metabolic outcomes in normal humans; a finding which will require confirmation by future studies.

Although this clinical study has revealed a significant amount of novel information regarding the physiological role of irisin in humans, much remains unknown regarding its function as a hormone and the regulation of FNDC5 synthesis and irisin secretion.


Story Source:

The above story is based on materials provided by Elsevier. Note: Materials may be edited for content and length.


Journal Reference:

  1. Joo Young Huh, Grigorios Panagiotou, Vassilis Mougios, Mary Brinkoetter, Maria T. Vamvini, Benjamin E. Schneider, Christos S. Mantzoros. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism, 2012; DOI: 10.1016/j.metabol.2012.09.002

Cite This Page:

Elsevier. "Physiological role of a novel hormone FNDC5/irisin revealed in humans." ScienceDaily. ScienceDaily, 1 October 2012. <www.sciencedaily.com/releases/2012/10/121001083542.htm>.
Elsevier. (2012, October 1). Physiological role of a novel hormone FNDC5/irisin revealed in humans. ScienceDaily. Retrieved October 24, 2014 from www.sciencedaily.com/releases/2012/10/121001083542.htm
Elsevier. "Physiological role of a novel hormone FNDC5/irisin revealed in humans." ScienceDaily. www.sciencedaily.com/releases/2012/10/121001083542.htm (accessed October 24, 2014).

Share This



More Health & Medicine News

Friday, October 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

WHO: Millions of Ebola Vaccine Doses by 2015

WHO: Millions of Ebola Vaccine Doses by 2015

AP (Oct. 24, 2014) The World Health Organization said on Friday that millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines would start being tested in March. (Oct. 24) Video provided by AP
Powered by NewsLook.com
Doctor in NYC Quarantined With Ebola

Doctor in NYC Quarantined With Ebola

AP (Oct. 24, 2014) An emergency room doctor who recently returned to the city after treating Ebola patients in West Africa has tested positive for the virus. He's quarantined in a hospital. (Oct. 24) Video provided by AP
Powered by NewsLook.com
Breakfast Debate: To Eat Or Not To Eat?

Breakfast Debate: To Eat Or Not To Eat?

Newsy (Oct. 23, 2014) Conflicting studies published in the same week re-ignited the debate over whether we should be eating breakfast. Video provided by Newsy
Powered by NewsLook.com
Ebola Fears Keep Guinea Hospitals Empty

Ebola Fears Keep Guinea Hospitals Empty

AP (Oct. 23, 2014) Fears of Ebola are keeping doctors and patients alike away from hospitals in the West African nation of Guinea. (Oct. 23) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins